• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Absolute Risk-Based Treatment Using Adaptive Blood Pressure Thresholds and Targets Is Crucial to Older Multimorbid Patients With High Fall Risk Guidelines Conversation
Source: Hypertension - May 9, 2018 Category: Cardiology Authors: Vernon Min Sen Oh Tags: High Blood Pressure, Hypertension, Treatment, Ethics and Policy, Quality and Outcomes, Cerebrovascular Disease/Stroke Guidelines Conversation Source Type: research

Blood Pressure-Related Risk Among Users Versus Nonusers of AntihypertensivesNovelty and Significance Epidemiology/Population
In conclusion, this population-based study demonstrated that the associations between BP and adverse outcomes were J-shaped among active antihypertensive users, but linear or flat and then increasing among nonusers or irregular users.
Source: Hypertension - May 9, 2018 Category: Cardiology Authors: Hae Hyuk Jung, Ji In Park, Jin Seon Jeong Tags: Nephrology and Kidney, Cardiovascular Disease, Epidemiology, Hypertension, Mortality/Survival Original Articles Source Type: research

20-HETE Excellence Award for Hypertension Research
Source: Hypertension - June 13, 2018 Category: Cardiology Authors: Richard J. Roman, Fan Fan Tags: Gene Expression & Regulation, Genetically Altered and Transgenic Models, Hypertension, Cerebrovascular Disease/Stroke Excellence Award for Hypertension Research Source Type: research

Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic ControlNovelty and Significance Type 2 Diabetes Mellitus and Hypertension
This study aimed to assess whether intensive blood pressure (BP) treatment has benefits in preventing cardiovascular events, including heart failure in patients with type 2 diabetes mellitus. Using the ACCORD BP trial (Action to Control Cardiovascular Risk in Diabetes Blood Pressure) data, hazard ratios for cardiovascular events with 95% confidence intervals were calculated using the Cox proportional hazard models to compare the time to the first cardiovascular event in patients receiving standard (n=2362) or intensive glycemic control (n=2371). The overall mean follow-up period was 4.5 years, and cardiovascular events wer...
Source: Hypertension - July 11, 2018 Category: Cardiology Authors: Tetsuro Tsujimoto, Hiroshi Kajio Tags: Hypertension Original Articles Source Type: research

Association Between Prepregnancy Cardiovascular Function and Subsequent Preeclampsia or Fetal Growth RestrictionNovelty and Significance Preeclampsia, Pregnancy, and Hypertension
Preeclampsia and fetal growth restriction during pregnancy are associated with increased risk of maternal cardiovascular disease later in life. It is unclear whether this association is causal or driven by similar antecedent risk factors. Clarification requires recruitment before conception which is methodologically difficult with high attrition rates and loss of outcome numbers to nonconception/miscarriage. Few prospective studies have, therefore, been adequately powered to address these questions. We recruited 530 healthy women (mean age: 35.0 years) intending to conceive and assessed cardiac output, cardiac index, strok...
Source: Hypertension - July 11, 2018 Category: Cardiology Authors: Fung L. Foo, Amita A. Mahendru, Giulia Masini, Abigail Fraser, Stefano Cacciatore, David A. MacIntyre, Carmel M. McEniery, Ian B. Wilkinson, Phillip R. Bennett, Christoph C. Lees Tags: Clinical Studies, Hemodynamics, Preeclampsia Original Articles Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18